Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCELTA: Stem Cells for Critical Limb Ischemia
NCT02454231Phase 3Completed
- Sponsor
- Università degli Studi di Firenze
- Start
- Sep 2009
- Primary completion
- May 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous CD14+CD34+ cells in critical limb ischemia (CLI), sponsored by Università degli Studi di Firenze. Started Sep 2009; status: completed.
02
Drugs
autologous CD14+CD34+ cells
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT02454231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02454231.